Deregulation of the expression of the fractalkine/fractalkine receptor complex in HIV-1-infected patients

Blood

Volumn 98, Issue 6, 2001, Pages 1678-1686

  Foussat, Arnaud ^a,b,c   Bouchet Delbos, Laurence ^a,b,c   Berrebi, Dominique ^a,b,c   Durand Gasselin, Ingrid ^a,b,c   Coulomb L'Hermine, Aurore ^a,b,c   Krzysiek, Roman ^a,b,c   Galanaud, Pierre ^a,b,c   Levy, Yves ^a,b,c   Emilie, Dominique ^a,b,c,d  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d Institut Paris Sud sur les Cytokines   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD123 ANTIGEN; CD45 ANTIGEN; CD83 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CX3C CHEMOKINE; FRACTALKINE; FRACTALKINE RECEPTOR; INTERLEUKIN 2; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; DNA POLYMORPHISM; GENE EXPRESSION REGULATION; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INTESTINE LYMPHATIC TISSUE; LYMPH NODE; LYMPHOID TISSUE; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; T LYMPHOCYTE; VIREMIA; VIRUS REPLICATION;

EID: 0035885918     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.6.1678     Document Type: Article

References (41)

1. Bazan JF, Bacon KB, Hardiman G, et al. A new class of membrane-bound chemokine with a CX3C motif. Nature. 1997;385:640-644.
2. Papadopoulos EJ, Sassetti C, Saeki H, et al. Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation. Eur J Immunol. 1999;29:2551-2559.
3. Harrison JK, Jiang Y, Wees EA, et al. Inflammatory agents regulate in vivo expression of fractaIkine in endothelial cells of the rat heart. J Leukoc Biol. 1999;66:937-944.
4. Foussat A, Coulomb-L'Hermine A, Gosling J, et al. Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human. Eur J Immunol. 2000;30:87-97.
5. Harrison J, Jiang Y, Chen S, et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci U S A. 1998;95:10896-10910.
6. Tong N, Perry SW, Zhang Q, et al. Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. J Immunol. 2000;164:1333-1339.
7. Combadiere C, Salzwedel K, Smith ED, et al. Identification of CX3CR1. J Biol Chem. 1998;273:23799-23804.
8. Imai T, Hieshima K, Haskell C, et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell. 1997;91:521-530.
9. Haskell CA, Cleary MD, Charo IF. Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction. J Biol Chem. 1999;274:10053-10058.
10. Fong AM, Robinson LA, Steeber DA, et al. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med. 1998;188:1413-1419.
11. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science. 1996;272:60-66.
12. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-314.
13. Faure S, Meyer L, Costagliola D, et al. Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science. 2000;287:2274-2277.
14. McDermott DH, Colla JS, Kleeberger CA, et al. Genetic polymorphism in CX3CR1 and risk of HIV disease. Science. 2000;290:2031.
15. Peuchmaur M, Emilie D, Crevon MC, et al. IL-2 mRNA expression in Tac-positive malignant lymphomas. Am J Pathol. 1990;136:383-390.
16. Emilie D, Peuchmaur M, Maillot MC, et al. Production of interleukins in HIV-1 replicating lymph nodes. J Clin Invest. 1990;86:148-159.
17. Zou W, Foussat A, Houhou S, et al. Acute upregulation of CCR5 expression by CD4+ T lymphocytes in HIV infected patients treated with interleukin-2. AIDS. 1999;13:455-463.
18. Tacchetti C, Favre A, Moresco L, et al. HIV is trapped and masked in the cytoplasm of lymph node follicular dendritic cells. Am J Pathol. 1997;150:533-542.
19. Cella M, Facchetti F, Lanzavecchia A, Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent Th1 polarization. Nat Immunol. 2000;1:305-310.
20. Barron MA, Blyveis N, Martin K, Wilson CC. Characterization of myeloid and lymphoid blood dendritic cell subsets in HIV-1-infected individuals [abstract]. Eighth Conference on Retroviruses and Opportunistic Infections. Chicago, IL, February 4-8, 2001.
21. Donaghy H, Qasi N, Pozniak A, et al. Can antiretroviral therapy restore the dendritic cell numbers in HIV-l 1 -infected patients [abstract]. Eighth Conference on Retroviruses and Opportunistic infections. Chicago, IL, February 4-8, 2001.
22. Ostrow MA, Justement SJ, Catanzaro A, et al. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1 infected and uninfected individuals. J Immunol. 1998;161:3195-3201.
23. Forster R, Schweigard G, Johann S, et al. Abnormal expression of the B-cell homing chemokine receptor BLR1 during the progression of acquired immunodeficiency syndrome. Blood. 1997;90:520-525.
24. Tedla N, Palladinetti P, Kelly M, et al. Chemokines and T lymphocyte recruitment to lymph nodes in HIV infection. Am J Pathol. 1996;148:1367-1373.
25. Trumpfheller C, Tenner-Racz K, Racz P, Fleischer B, Frosch S. Expression of macrophage inflammatory protein (MIP)-1a, MIP-1β, and RANTES genes in lymph nodes from HIV+ individuals: correlation with a Th1-type cytokine response. Clin Exp Immunol. 1998;12:92-99.
26. Wang L, Robb CW, Cloyd MW. HIV induces homing of resting T lymphocytes to lymph nodes. Virology. 1997;228:141-152.
27. Bucy RP, Hockett RD, Derdeyn CA, et al. Initial increase in blood CD4+ lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. J Clin Invest. 1999;103:1390-1398.
28. Pakker NG, Notermans DW, de Boers RJ, et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med. 1998;4:208-214.
29. Mackay CR. Homing of naive, memory and effector lymphocytes. Curr Opin Immunol. 1993;5:423-427.
30. Oppenheimer-Marks N, Lipsky PE. Migration of naive and memory T cells. Immunol Today. 1997;18:456-457.
31. Notermans DW, Pakker NG, Hamann D, et al. Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated HIV-1-infected adults. J Infect Dis. 1999;180:1050-1056.
32. Goldrath AW, Bevan MJ. Selecting and maintaining a diverse T-cell repertoire. Nature. 1999;402:255-262.
33. Pope M, Betjes MGH, Romani N, et al. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell. 1994;78:389-398.
34. Granelli-Piperno A, Delgado E, Finkel V, Paxton W, Steinman RM. Immature dendritic cells selectively replicate macrophage tropic (M-tropic) HIV-1, while mature cells efficiently transmit both M- and T-tropic virus to T cells. J Virol. 1998;72:2733-2737.
35. Geijtenbeek TBH, Kwon DS, Torensma R, et al. DC-SIGN, a dendritic cell-specific HIV-1 binding protein that enhances trans-infection of T cells. Cell. 2000;100:587-597.
36. Rissoan MC, Soumelis V, Kadowaki N, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science. 1999;283:1183-1186.
37. Liu YJ, Bloom B. Introduction: Th2-inducing DC2 for immunotherapy. Blood. 2000;95:2482-2483.
38. Zou W, Dulioust A, Fior R, et al. Increased Th2-type cytokine production in chronic HIV infection is due to IL-13 rather than IL-4. AIDS. 1997;11:533-534.
39. Gilliet MF, Ho S, Liu YL. Human type-2 dendritic cells (DC2) induce IL-10-producing regulatory CD8 T cells [abstract]. Keystone Symposia: Dendritic Cells: Interfaces with Immunobiology and Medicine. Taos, NM, March 12-18, 2001.
40. Appay V, Nixon DF, Donahoe SM, et al. HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med. 2000;192:63-75.
41. Cella M, Jarrossay D, Facchetti F, et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med. 1999;5:919-923.